Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending dose and food-effect study of oral WCK 4873 in healthy adults
NL-OMON38693Active, not recruiting
- Sponsor
- Wockhardt
- Start
- Mar 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in bacterial pneumonia and Airways Infection comparing WCK 4873 with Placebo (2 arms). Primary endpoints: Pharmacokinetics, Safety and 1 more. Started Mar 2013; status: active, not recruiting.
02
Drugs
nafithromycin
03
Conditions
bacterial pneumoniaAirways Infection
Beyond the preview
Go deeper on NL-OMON38693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38693.